Page 98

House Bill No. 5506

Public Act No. 22-118 98 of 739

policy, a prescribing practitioner shall first establish a provider-patient relationship with the patient or patients who will receive collaborative drug therapy or devices. Each patient's collaborative drug therapy or device management shall be [governed by a written protocol which may include guideline-directed management established by the treating physician or advanced practice registered nurse in consultation with the pharmacist. For purposes of this subsection, a "provider-patient relationship" is a relationship based on (1) the patient making a medical complaint, (2) the patient providing a medical history, (3) the patient receiving a physical examination, and (4) a logical connection existing between the medical complaint, the medical history, the physical examination and any drug prescribed for the patient] based on a diagnosis made by such patient's prescribing practitioner or a specific test set forth in a collaborative drug therapy management agreement or collaborative drug therapy management policy. [(b)] (c) A collaborative drug therapy management agreement or collaborative drug therapy management policy may authorize a [pharmacist to implement] qualified pharmacist or qualified pharmacists to initiate, modify, continue, discontinue or deprescribe a drug therapy, or initiate, continue or discontinue use of, or deprescribe, a device, that has been prescribed for a patient, order associated laboratory tests and administer drugs, all in accordance with a patient- specific or patient population-specific written protocol [. Such agreement] or collaborative drug therapy care plan, but shall not authorize a qualified pharmacist or qualified pharmacists to establish a port to administer parenteral drugs. A collaborative drug therapy management agreement or collaborative drug therapy management policy may specifically address issues that may arise during a medication reconciliation and concerns related to polypharmacy that enable an authorized qualified pharmacist or qualified pharmacists to [implement] initiate, modify, continue, discontinue or deprescribe drug therapy. In instances where drug therapy is discontinued or